TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer

Conditions:   Breast Cancer;   Early-stage Breast Cancer;   High Risk Breast Carcinoma Interventions:   Drug: Abemaciclib;   Drug: Tamoxifen;   Drug: Anastrozole;   Drug: Letrozole;   Drug: Exemestane;   Drug: LHRH Agonist Sponsors:   Dana-Farber Cancer Institute;   Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials